Mini organs, big breakthroughs: Scaling organoids for next-generation drug discovery
Experts explore the technologies and innovations transforming organoids into scalable platforms for drug discovery
Experts explore the technologies and innovations transforming organoids into scalable platforms for drug discovery
Researchers are uncovering previously unknown sources of PFAS using robotic sample preparation and high-resolution mass spectrometry
In this guest blog post, Bright Kondwani Kamanga discusses his everyday life in the lab, the challenges faced, and the role of technology in overcoming those hurdles
TSKgel Amide-80 and TSKgel NH2-100 HILIC columns from Tosoh Bioscience are first class columns when it comes to separations of hydrophilic compounds like peptides, carbohydrates, polar natural substances, amino acids, oligonucleotides, organic polar acids and bases, even proteins.
Waters has acquired technology assets and intellectual property rights of Megadalton Solutions, an early-stage developer of charge detection mass spectrometry (CDMS).
Responses were seen in patients who were not treated with prior KRAS G12C inhibitors as well as those whose disease progressed on prior KRAS G12C inhibitors
Absolute characterization of protein-protein and other macromolecular interactions with composition-gradient multi-angle light scattering.
Fast, High-Sensitive Measurements through an Ultra-Compact Design

The Ceres Nanosciences Nanotrap® Virus Capture Kit provide a way to concentrate viruses from complex biological matrices in order to have high quality input material for your downstream analytical methods
2mL of Nanotrap ® Non-Magnetic Virus Particles (10 x 0.2 mL)
MS analyzes possible over a wide mass range, even with small sample volumes
Tangential flow filtration (TFF) cassette eliminates the need for feed flow rate, TMP, and permeate flux calculations
Join us on Monday, September 21, to learn about assay development for high-throughput screening
Three therapeutic targets selected across high‑value clinical indications pipeline planned for four radiotherapy assets with in vivo data expected by end of 2026